MedConnect Fall 2015

MedImpact has published the latest issue of MedConnect, our quarterly newsletter. Features in this issue include:

  • 340B ─ HRSA Releases Much-anticipated 340B MegaGuidance
  • Specialty Rx ─ High Cholesterol Treatments: Does New Equal Improved?
  • Self-funded ─ High Deductible Health Plans (HDHPs) – Market Changes and Growth since the Passage of the ACA
  • MCO Commercial ─ Reduce Costs with MedImpact’s Pharmacy Flu Program
  • Top Drugs ─ Top Rheumatoid Arthritis (RA) Drugs by Claim Cost and Volume
  • Drug Info ─ PCSK9 Inhibitors: A Glimpse at the Future Treatment of High Cholesterol
  • MedMatters ─ The latest news from MedImpact
  • Upcoming Events – Registration for the MedImpact 2016 Annual Conference Now Open

Read the Newsletter

  • Email